Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 518-525

  Moss, R B ^a,b   Hsu, Y P ^a   Olds, L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cystic fibrosis; Cytokines; Inflammation; Interferon; Interleukin

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION;

ADOLESCENT; ADULT; CELL SEPARATION; CELLS, CULTURED; CHILD; CYSTIC FIBROSIS; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; TETRADECANOYLPHORBOL ACETATE;

EID: 0034046253     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01232.x     Document Type: Article

References (45)

1. 1 Khan TZ, Wagener JS, Bost T, Martinez J, Accurso F, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151:1075-82.
2. 2 Balough KR, McCubbin M, Weinberger M, Smits W, Ahrens R, Pick R. The relationship between infection and inflammation in the early stages of lung disease in cystic fibrosis. Pediatr Pulmonol 1995; 20:63-70.
3. 3 Heerecken AV, Walenga R, Konstan MW, Bonfield T, Davis PB, Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa. J Clin Invest 1997; 100:2840-5.
4. 4 Noah TL, Blach HR, Cheng PW, Wood RE, Leigh MW. Nasal and bronchoalveolar lavage cytokines in early cystic fibrosis. J Infect Dis 1997; 175:638-47.
5. 5 Tabary O, Zahm JM, Hinnrasky J et al. Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. Am J Physiol 1998; 153:921-30.
6. 6 Bonfield TL, Konstan MW, Berger M. Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol 1999; 104:72-78.
7. 7 Moss RB. Pathways to inflammation in cystic fibrosis. Pediatr Pulmonol 1996; Suppl. 13:158-60.
8. 8 Chen JH, Schulman H, Gardner P. A cAMP-regulated chloride channel in lymphocytes that is affected in cystic fibrosis. Science 1989; 243:657-60.
9. 9 McDonald TV, Nghiem PT, Gardner P, Martens CL. Human lymphocytes transcribe the cystic fibrosis transmembrane conductance regulator gene and exhibit CF-defective cAMP-regulated chloride current. J Biol Chem 1992; 267:3242-8.
10. 10 Dong Y, Chao AC, Kouyama K, Hsu YP, Bocian RC, Moss RB, Gardner P. Activation of CFTR chloride channel by nitric oxide in human T lymphocytes. EMBO J 1995; 14:2700-7.
11. 11 Moss RB, Bocian RC, Hsu YP, Dong Y, Wei T, Kemna M, Gardner P. Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator. Clin Exp Immunol 1996; 106:374-88.
12. 12 Misumi Y, Misumi Y, Miki K, Takatsuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J Biol Chem 1986; 261:11398-403.
13. 13 Shea TB. An inexpensive densitometric analysis system using a MacIntosh computer and a desktop scanner. Biotechniques 1994; 16:1126-8.
14. 14 Jung T, Schauer U, Heusser C, Neumann C, Rieger C. Detection of intracellular cytokines by flow cytometry. J Immunol Methods 1993; 159:197-207.
15. 15 Abrams JS. Immunoenzymatic assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies. In: Coligan J, ed. Current protocols in immunology, Suppl. 13. New York: Wiley-Interscience, 1995:6.20.
16. 16 Bedard M, McClure CD, Schiller NL, Francoeur C, Cantin A, Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am J Respir Cell Mol Biol 1993; 9:455-62.
17. 17 Armstrong DS, Grimwood K, Carlin JB et al. Lower airways inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 1997; 156:1197-204.
18. 18 Black HR, Yankaskas JR, Johnson LG, Noah TL. Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-α and respiratory syncytial virus stimulation. Am J Respir Cell Mol Biol 1998; 19:210-5.
19. 19 Jones MM, Seillheimer DK, Pier GB, Rosen RD. Increased elastase secretion by peripheral blood monocytes in cystic fibrosis patients. Clin Exp Immunol 1990; 80:344-9.
20. 20 Regelmann WE, Skubitz KM, Herron JM. Increased monocyte oxidase activity in cystic fibrosis homozygotes and heterozygotes. Am J Respir Cell Mol Biol 1991; 5:27-33.
21. 21 Dagli E, Wamer JA, Besley CR, Warner JO. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease. Arch Dis Child 1992; 67:479-81.
22. 22 Pfeiffer KD, Hueksteadt TP, Hoidal JR. Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am J Respir Cell Mol Biol 1993; 9:511-9.
23. 23 Koller DY, Urbanek R, Gotz M. Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis. Am J Respir Crit Care Med 1995; 152:629-33.
24. 24 DiMango EM, Zar HJ, Bryan R, Prince A. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J Clin Invest 1995; 96:2204-10.
25. 25 Witko-Sarsat V, Allen RC, Paulais M, Nguyen AT, Bessou G, Lenoir G, Descamps-Latcha B. Disturbed myeloperoxidase-dependent activity of neutrophils in cystic fibrosis homozygotes and heterozygotes, and its correction by amiloride. J Immunol 1996; 157:2728-35.
26. 26 Kammouni W, Figarella C, Marchand S, Merten M. Altered cytokine production by cystic fibrosis tracheal gland serous cells. Infect Immun 1997; 65:5176-83.
27. 27 Zahm JM, Gaillard D, Dupuit F, Hinnrasky J, Porteous D, Dorin JR, Puchelle E. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. Am J Physiol 1997; 272:C853-9.
28. 28 DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-KB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis epithelial cells. J Clin Invest 1998; 101:2598-605.
29. 29 Russell KJ, McRedmond J, Mukherji N et al. Neutrophil adhesion molecule surface expression and responsiveness in cystic fibrosis. Am J Respir Crit Care Med 1998; 157:756-61.
30. 30 Yssel H, De Waal Malefyt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H, de Vries JE. IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992; 149:2378-84.
31. 31 Gonzalez S, Beck L, Wilson N, Spiegelberg HL. Comparison of interferon-γ and interleukin-4 production by peripheral blood mononuclear cells and isolated T cells after activation with polyclonal T cell activators. J Clin Lab Anal 1994; 8:277-83.
32. 32 Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects, patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
33. 33 Harada Y, Watanabe S, Yssel H, Arai K. Factors affecting the cytokine production of human T cells stimulated by different modes of activation. J Allergy Clin Immunol 1996; 98:5161-73.
34. 34 Lai CKW, Ho S, Chan CHS, Chan J, Choy D, Leung R, Lai K. Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis. Chest 1997; 111:606-11.
35. 35 Johansen HK, Hougen HP, Rygaard J, Hoiby N. Interferon-gamma treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats. Clin Exp Immunol 1996; 103:212-8.
36. 36 Johansen HK, Cryz Sj Jr, Hougen HP, Moser C, Hoiby N. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle. Behring Inst Mitt 1997; 98:269-73.
37. 37 Moser C, Johansen HJ, Song Z, Hougen HP, Rygaard J, Hoiby N. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th 1 responding C3H/HeN mice. APMIS 1997; 105:838-42.
38. 38 Boguniewicz M, Martin RJ, Martin D, Gibson U, Celniker A, Williams M, Leung DY. The effects of nebulized recombinant interferon-gamma in asthmatic airways. J Allergy Clin Immunol 1995; 95:133-5.
39. 39 Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Med 1995; 1:890-3.
40. 40 Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995; 152:2111-8.
41. 41 Bonfield TL, Konstan MW, Burfeind P, Panuska JR, Hilliard JB, Berger M. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is down-regulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995; 13:257-61.
42. 42 Calahan MD, Lewis RS. Regulation of chloride channels in lymphocytes. Curr Topic Membr 1994; 42:103-29.
43. - flux [Abstr.]. Am J Resp Crit Care Med 1997; 155:A198.
44. 44 Alton EWF, Stern M, Farley R et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999; 353:947-54.
45. 45 Wagner JA, Messner AH, Moran ML et al. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in CF patients with antrostomies [Abstr.]. Pediatr Pulmonol 1999; Suppl. 19:223-4.